You have 9 free searches left this month | for more free features.

Event-related potentials

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune-related Adverse Events Refractory to Standard Therapy and

Recruiting
  • Immune-related Adverse Event
  • Extracorporeal photopheresis
  • Other immunosuppressive or immunomodulatory drugs
  • Munich, Germany
    LMU Klinikum Hauttumorzentrum
Jan 17, 2023

Executive Function Trial in Taipei (concurrent exercise, aerobic exercise)

Completed
  • Executive Function
  • concurrent exercise
  • aerobic exercise
  • Taipei, Taiwan
    Department of Physical Education and Sport Sciences, National Ta
Mar 29, 2022

Mild Cognitive Impairment Trial in Lexington (Neurofeedback)

Recruiting
  • Mild Cognitive Impairment
  • Neurofeedback
  • Lexington, Kentucky
    Lexington VA Medical Center, Lexington, KY
Oct 6, 2022

Exercise Training, Neurocognitive Function Trial in Taipei (aerobic exercise group (AE), aerobic exercise with virtual reality

Recruiting
  • Exercise Training
  • Neurocognitive Function
  • aerobic exercise group (AE)
  • +3 more
  • Taipei, Taiwan
    Department of Physical Education and Sport Sciences, National Ta
Apr 1, 2022

Executive Function Trial in Taipei (resistance-aerobic exercise, RA, aerobic-resistance exercise, AR)

Completed
  • Executive Function
  • resistance-aerobic exercise, RA
  • aerobic-resistance exercise, AR
  • Taipei, Taiwan
    Department of Physical Education and Sport Sciences, National Ta
Mar 29, 2022

Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)

Not yet recruiting
  • Immune-related Adverse Event
  • +3 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Dec 15, 2022

Autism Spectrum Disorder Trial in New Haven (MAGSTIM Rapid2 TMS system)

Not yet recruiting
  • Autism Spectrum Disorder
  • MAGSTIM Rapid2 TMS system
  • New Haven, Connecticut
    Yale Psychiatric Hospital
Nov 15, 2023

Pain, Neonatal Trial in Halifax (Breastfeeding, 24% oral sucrose)

Completed
  • Pain
  • Neonatal
  • Breastfeeding
  • 24% oral sucrose
  • Halifax, Nova Scotia, Canada
    Britney Benoit
Nov 6, 2019

Residual Cognitive Functions in Severe Alterations of

Completed
  • Consciousness Disorder
  • Cognitive Impairment
  • Neurowave Group
  • Messina, Italy
    IRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 27, 2023

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

Medication Adherence, Medication Nonadherence, Adverse Drug Event Trial in Lexington (Collaborative nurse-pharmacist counseling)

Not yet recruiting
  • Medication Adherence
  • +2 more
  • Collaborative nurse-pharmacist counseling
  • Lexington, Kentucky
    University of Kentucky
Apr 3, 2023

Alcohol Use Disorder Trial in Ann Arbor (Bias retraining, Sham retraining)

Active, not recruiting
  • Alcohol Use Disorder
  • Bias retraining
  • Sham retraining
  • Ann Arbor, Michigan
    University of Michigan Addiction Research Center
Dec 16, 2021

Exercise, Cognitive Function Trial in Taipei (low-volume moderate-intensity group, moderate-volume moderate-intensity group,

Recruiting
  • Exercise
  • Cognitive Function
  • low-volume moderate-intensity group
  • +4 more
  • Taipei, Taiwan
    National Taiwan Normal University
May 9, 2022

Intractable Epilepsy Trial in Paris (Evoked related potentials)

Active, not recruiting
  • Intractable Epilepsy
  • Evoked related potentials
  • Paris, France
    GHU Paris - Sainte Anne
Jul 6, 2021

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

Obesity Trial (BI 456906, Placebo)

Not yet recruiting
  • Obesity
  • BI 456906
  • Placebo
  • (no location specified)
Oct 4, 2023

Adverse Events in Patients Treated With Immune Check Point

Recruiting
  • Immune-related Adverse Event
  • Antiinflammatory/DMARDs
  • Kristiansand, Norway
  • +4 more
Sep 15, 2022

Speech Perception Impairment Follow Complete Recovery of Sudden

Not yet recruiting
  • Sudden Sensorineural Hearing Loss
  • speech in noise test
  • (no location specified)
Nov 7, 2022

HIV Dementia Trial (electroencephalography (EEG) and event related potentials (ERP))

Unknown status
  • HIV Dementia
  • electroencephalography (EEG) and event related potentials (ERP)
  • (no location specified)
Jul 9, 2019

Neuroinflammation and Alzheimer's Pathology in POCD

Recruiting
  • Post-Operative Confusion
  • +2 more
  • Montreal Cognitive Assessment
  • +7 more
  • Knoxville, Tennessee
    Robert M Craft
May 13, 2022

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Pain, Quality of Life, Injection Site Reaction Trial in Durham (FLUAD® Quadrivalent, Fluzone® HD Quadrivalent, SHINGRIX®)

Recruiting
  • Pain
  • +3 more
  • FLUAD® Quadrivalent
  • +2 more
  • Durham, North Carolina
    Duke University
Jan 19, 2023

Esophageal Tumors, Adverse Drug Event Trial in Nanjing (dietary supplement, drug, radiation)

Recruiting
  • Esophageal Neoplasms
  • Adverse Drug Event
  • Nutritional Support Team
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Mar 23, 2023

MDD, Post Traumatic Stress Disorder Trial in Newark, Cleveland, Seattle (Positive Processes and Transition to Health (PATH))

Recruiting
  • Major Depressive Disorder
  • Post Traumatic Stress Disorder
  • Positive Processes and Transition to Health (PATH)
  • Newark, Delaware
  • +2 more
Apr 28, 2022